bevacizumab,trifluridine tipiracil
roche,otsuka,taiho pharma
[]
 important practice changing trials. sunlight trial. tas-102 bev tas-102 os/pfs endpoints met. has already been in use in since listed as an option guidelines. #gi23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.